Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.30 |
| ▸ | FNTB | P49356 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25869640 | 0.98 | ALDH1A1 (0.36) | ALDH1A1LMNASLC15A2KDM4EUSP2 | |
| SCHEMBL25869638 | 0.95 | ACHE (0.31) | ALDH1A1LMNAKDM4EUSP2MMP9 | |
| SCHEMBL25869656 | 0.91 | FNTA (0.37) | ALDH1A1LMNAKDM4EUSP2MMP9 | |
| SCHEMBL25869631 | 0.91 | PAOX (0.39) | ALDH1A1LMNAKDM4EUSP2MMP9 | |
| SCHEMBL25869641 | 0.89 | PAOX (0.34) | ALDH1A1FNTAFNTB | |
| SCHEMBL25869634 | 0.87 | TDP1 (0.31) | ALDH1A1LMNAKDM4EUSP2MMP9 | |
| SCHEMBL25869620 | 0.87 | PAOX (0.39) | ALDH1A1LMNAKDM4EUSP2MMP9 | |
| SCHEMBL25869626 | 0.86 | MAPT (0.44) | TSHR | |
| SCHEMBL25869628 | 0.84 | CA2 (0.38) | ALDH1A1TSHR | |
| SCHEMBL25869645 | 0.83 | ALDH1A1 (0.39) | ALDH1A1LMNASLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708324-B2 | Sulfuric acid ester or salt thereof, and surfactant | DAIKIN INDUSTRIES. LTD. (JP) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708324-B2 | Sulfuric acid ester or salt thereof, and surfactant | SRP54, NR4A1, NR4A3 | ALDH1A1 3345/4885LMNA 4598/4885SLC15A2 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.